Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy-Reference-Cited by-同舟云学术

Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy

Published:2010-10-06 Issue:2 Volume:16 Page:118-124
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yakushijin Yoshihiro,Shikata Hisaharu,Takaoka Ikue,Horikawa Tamami,Takeuchi Kazuhito,Yamanouchi Jun,Azuma Taichi,Narumi Hiroshi,Hato Takaaki,Yasukawa Masaki

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-010-0134-x.pdf

Reference22 articles.

1. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Eng J Med 327:28–35

2. Roilides E, Walsh TJ, Pizzo PA et al (1991) Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 163:579–583

3. Erbe DV, Collins JE, Shen L et al (1990) The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol Immunol 27:57–60

4. Carulli G (1997) Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions. Haematologica 82:606–616

5. Rouveix B, Giroud JP, Levacher M (2001) G-CSF: mode of action and antiinfective activities. Antibiotiques 3:83–89

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients;Iraqi Journal of Hematology;2022

2. SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders;Expert Review of Hematology;2018-01-03

3. Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma;Scientific Reports;2017-06-30

4. Cost‐effectiveness of granulocyte colony‐stimulating factor prophylaxis in chemotherapy‐induced febrile neutropenia among breast cancer and Non‐Hodgkin's lymphoma patients under Taiwan's national health insurance system;Journal of Evaluation in Clinical Practice;2016-08-04

5. Suboptimal Duration of Granulocyte Colony–stimulating Factor Use and Chemotherapy-induced Neutropenia in Women Diagnosed With Breast Cancer;Clinical Therapeutics;2014-09